Ocugen OCGN
NASDAQ OCGN
$0.96 +0.01 (+1.09%)
At close: Nov 11, 2026 · 4:00 PM EST

Ocugen (OCGN) Construction in Progress (2013 - 2016)

Updated

Analysis

Ocugen (OCGN) Construction in Progress (2013 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Ocugen 322.34 Mn 87.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 759,000.00
Mar 31, 2016 571,000.00
Dec 31, 2015 547,000.00
Dec 31, 2014 270,000.00
Dec 31, 2013 145,000.00
API Access

Ocugen Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=OCGN&period=max&api_key=YOUR_API_KEY